Precision Medicine for Hepatoblastoma
Identification of novel therapies and predictive biomarkers using a unique EU biorepository
El objectivo es comprender mejor los mecanismos moleculares involucrados en la agresividad tumoral y la falta de respuesta a la terapia farmacológica
Project leaders
In the PMed4HB project, a multidisciplinary team of 22 researchers from 5 centers of research excellence in Spain is participating. The principal investigators from each center bring extensive and complementary expertise in the field of liver diseases and cancer, as well as in the development of innovative models with the patient always at the center of research. This provides an excellent opportunity to study hepatoblastoma with a synergistic and innovative approach.
Paedriatic Hepatic International Tumour Trial (PHITT)
The foundation of the PMed4HB project is a collection of samples from patients with hepatoblastoma, unique in the world. This collection, initiated by Dr. Amengol in 2010, has been made possible thanks to the support of families and patients for translational research, as well as the establishment of an extensive collaborative network with leading hospitals in Spain and various European countries participating in the Paediatric Hepatic International Tumour Trial (PHITT).